Effect of laryngeal anesthesia on pulmonary function testing in normal subjects.
Pulmonary function tests (PFT) were performed on 11 normal subjects before and after topical anesthesia of the larynx. The PFT consisted of flow volume loops and body box determinations of functional residual capacity and airway resistance, each performed in triplicate. After the first set of tests, cotton pledgets soaked in 4% lidocaine were held in the pyriform sinuses for 2 min to block the superior laryngeal nerves. In addition, 1.5 ml of 10% cocaine was dropped on the vocal cords via indirect laryngoscopy. PFT were repeated 5 min after anesthesia. Besides routine analysis of the flow volume loops, areas under the inspiratory (Area I) and expiratory (Area E) portions of the loops were calculated by planimetry. Area I, peak inspiratory flow (PIF), as well as forced inspiratory flow at 25, 50, and 75% forced vital capacity (FVC), decreased after anesthesia. Peak expiratory flow decreased after anesthesia, but Area E and forced expiratory flow at 25, 50, and 75% FVC were unchanged. This protocol also was performed in 12 normal subjects with isotonic saline being substituted for the lidocaine and cocaine. In this group, no significant differences were observed when flow volume loop parameters were compared before and after topical application of saline. In 5 spontaneously breathing anesthetized dogs, posterior cricoarytenoid muscle and afferent superior laryngeal nerve activity were recorded before and after laryngeal anesthesia performed with the same procedure used in the human subjects. Laryngeal anesthesia resulted in a substantial decrease or a complete disappearance of afferent SLN activity recorded during unobstructed and obstructed respiration. The data suggest that laryngeal receptors help modulate upper airway patency in man.
Kuna
S T
ST
Department of Internal Medicine, University of Texas Medical Branch, Galveston 77550.
Woodson
G E
GE
Sant'Ambrogio
G
G
D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D000772:Anesthesia, Local; D000818:Animals; D004285:Dogs; D005260:Female; D005652:Functional Residual Capacity; D006801:Humans; D007821:Laryngeal Muscles / Q000502:physiology; D007830:Larynx / Q000187:drug effects* / Q000502:physiology; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D012123:Pulmonary Ventilation / Q000187:drug effects; D012129:Respiratory Function Tests; D012965:Sodium Chloride / Q000494:pharmacology
D012965:Sodium Chloride; D008012:Lidocaine